-
May 16, 2023, 7:26 pm172 pts
Ars Technica
Enlarge / The flu virus, showing the H and N proteins on its surface. (credit: CDC) An mRNA-based flu vaccine designed to offer long-lasting protection against a broad range of influenza viruses is now in a phase I clinical trial, the National Institutes of Health announced this week. The trial brings the…
Trending Today on Tech News Tube
Tech News Tube is a real time news feed of the latest technology news headlines.
Follow all of the top tech sites in one place, on the web or your mobile device.
Follow all of the top tech sites in one place, on the web or your mobile device.
